Biotricity is at the leading edge of professional and personal remote medical monitoring
Biotricity is advancing the capabilities of remote biometric technology to improve the lives of people with chronic medical conditions. Our approach is to develop complementary technologies for diagnostic use by physicians and long-term use by individuals. Our goal is to further progress against a number of chronic illnesses. Our first target is the world’s leading cause of death: cardiovascular disease.
We’ve created real-time, high-precision remote monitoring technology used in medical research. Building upon our expertise, we’ve now developed Bioflux,1, 2 a remote cardiac monitoring system for use by physicians in testing and diagnosis. And we’re developing a personal monitoring device, Biolife, that will empower individuals to better manage their conditions and enhance the quality of lives.
The challenge is immense, but so is the opportunity for transformative change that will improve patient outcomes and curb healthcare costs.
More than half of adults in the US suffer from at least one chronic disease, and almost one-third have multiple chronic conditions.3 Seven of the top ten causes of death in the US are chronic diseases,4 with cardiovascular disease alone responsible for 30.8% of all deaths.5
In most cases, these conditions are preventable through lifestyle changes. However, the hard reality, with which doctors contend every day, is that the effects of these conditions often manifest too gradually for people to recognize. And it falls to the healthcare system to deal with these diseases after they’ve advanced to a serious stage, often at great financial cost. It was recently estimated that 86% of all healthcare spending in the US goes to the treatment of those with chronic diseases.3
US adults with at least one chronic disease
Number of chronic diseases in list of top 10 causes of death
Healthcare dollars spent on chronic diseases
It is therefore vital to develop technology that enhances doctors’ ability to detect and diagnose these conditions—and to do so early enough for treatments to have their greatest effect. It is also crucial to follow that up with personal devices that provide feedback reinforcing patients’ adherence to doctors’ instructions after diagnosis.
Achieving these twin goals is Biotricity’s mission.
With the development of our Bioflux and Biolife systems, we’re tackling cardiovascular disease. And we will move forward from there, applying our proven expertise in remote medical monitoring to the development of professional and personal systems that will aid in the fight against other chronic diseases, as well.
1. Hardware 510(k) clearance pending [return]
2. Software FDA approved [return]
3. Gerteis, J., Izrael, D., Deitz, D., LeRoy, L., Ricciardi, R., Miller, T., & Basu, J. (2014). Multiple chronic conditions chartbook. Rockville, MD: Agency for Healthcare Research and Quality (AHRQ) Publications, US Department of Health and Human Services. [return]
4. Kochanek, K. D., Murphy, S. L., Xu, J., & Tejada-Vera, B. (2016). Deaths: final data for 2014. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 65(4), 1. [return]
5. Mozaffarian, D., et al. (1 November 2016). Heart disease and stroke statistics-2016 update. Circulation, 134(18), e148. [return]